cytochalasin-d and Anaphylaxis

We investigated the effect of cytochalasin D on anaphylaxis. Cytochalasin D dose-dependently inhibited systemic anaphylaxis induced by compound 48/80 in rats. Especially, cytochalasin D inhibited compound 48/80-induced systemic anaphylaxis 100% with a dose of 1 microg g-1 body weight (BW). Cytochalasin D significantly inhibited serum histamine levels induced by compound 48/80. Cytochalasin D (10(-1) microg g-1 BW) also inhibited local anaphylaxis activated by anti-dinitrophenyl (DNP) IgE to 79.6+/-1.8%. Cytochalasin D dose-dependently inhibited histamine release from the rat peritoneal mast cells activated by compound 48/80 or anti-DNP IgE. The level of cAMP in rat peritoneal mast cells, when cytochalasin D was added, transiently and significantly increased about fourfold compared with that of basal cells. Our studies provide evidence that cytochalasin D will be beneficial in the treatment of anaphylaxis.

Topics: Anaphylaxis; Animals; Anti-Asthmatic Agents; Cromolyn Sodium; Cyclic AMP; Cytochalasin D; Histamine Release; Immunoglobulin E; Mast Cells; Nucleic Acid Synthesis Inhibitors; p-Methoxy-N-methylphenethylamine; Passive Cutaneous Anaphylaxis; Rats; Rats, Wistar